The different types and stages of folate receptor alpha expression in endometrial carcinoma and assessment on its diagnostic performance
10.3969/j.issn.1006-5725.2018.04.017
- VernacularTitle:不同分型分期子宫内膜癌叶酸受体α的表达及诊断性能评估
- Author:
Yinghui LIU
1
;
Jinyan LI
;
Youming WU
;
Meiling LI
;
Jiamin ZHU
;
Shuming HE
Author Information
1. 南方医科大学第二临床医学院 广州510515
- Keywords:
endometrial carcinoma;
folate receptor alpha(FRA);
CA125;
diagnostic performance
- From:
The Journal of Practical Medicine
2018;34(4):592-595
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the folate receptor alpha(FRA)expression in different types and stages of in endometrial carcinoma(EC). The sensitivity and specificity of FRA testing were compared with CA125 to evaluate its diagnostic performance.Methods Serum from 50 cases of EC patients and 30 cases of normal patients was collected.Tissue from 83 cases of typeⅠEC and 30 cases of normal endometrium and typeⅡEC were collected. The expression of serum FRA was detected by ELISA.The expression ofserum CA125 was detected by electrochemi-luminescence.The expression of FRA and CA125 in tissues was detected by immunohistochemistry. Results The rate of elevated FRA expression of in typeⅠEC tissue was higher than that in typeⅡEC(P < 0.05). The rate of elevated FRA expression in type I EC was higher than that in the early stage(P < 0.05). The ROC curve showed that the sensitivity and specificity of FRA was higher than these of CA125′s. Further,they are higher in the com-bined serum FRA and CA125.Conclusions This study shows that the FRA expression level in endometrial carci-noma varies in different subtypes,indicating the potential different pathogeneses. The rate of elevated FRA expression in type I endometrial carcinoma was higher than that in the early stage. This provides the possibility for the application of FRA targeted fluorescent developer in advanced endometrial carcinoma meticulous surgery. Combination of FRA and CA125 have better diagnostic value in detecting EC.
